Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-19T10:33:09.241Z Has data issue: false hasContentIssue false

P-1298 - Bilirubin and Brief Psychotic Disorder

Published online by Cambridge University Press:  15 April 2020

R. Rodriguez
Affiliation:
Consorci Sanitari de Terrassa, Barcelona, Spain
A. Roca
Affiliation:
Consorci Sanitari de Terrassa, Barcelona, Spain
B. Piñeiro
Affiliation:
Consorci Sanitari de Terrassa, Barcelona, Spain
G. Conangla
Affiliation:
Consorci Sanitari de Terrassa, Barcelona, Spain
C. Enero
Affiliation:
Consorci Sanitari de Terrassa, Barcelona, Spain
I. Ramos
Affiliation:
Consorci Sanitari de Terrassa, Barcelona, Spain
V. Valles
Affiliation:
Consorci Sanitari de Terrassa, Barcelona, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Recent studies have suggested an association between elevated levels of bilirubin and psychotic spectrum disorders. The aim of our study was to compare the levels of bilirubin in the different psychotic disorders among themselves and with other mental disorders.

Method

Observational, retrospective, in a sample of patients admitted to the Acute Psychiatric Unit between January 2007 and December 2009. We included all patients with plasma concentrations of bilirubin in the blood analysis. We excluded patients with toxic abuse and alterations in the liver reflected in increased transaminases.

Results

The final sample of 523 patients. Patients with psychotic disorder had bilirubin levels significantly higher than patients with other diagnosis (p < 001).

Psychotic disorders were subdivided into 5 groups: schizophrenia (N = 76), schizoaffective disorder (N = 53), delusional disorder (N = 21), brief psychotic disorder (N = 29) and other unspecified psychotic disorders (N = 34). The brief psychotic disorder patients had bilirubin levels significantly higher than other categories of the same spectrum (p < 0.001).

Conclusions

The psychotic spectrum patients have higher bilirubin levels at admission than other diagnostic entities, and this increase is mainly explained by Brief Psychotic Disorder. Bilirubin figures correlate negatively with psychotic symptoms days, so the brief psychotic disorder, is proclaimed as an ideal model for the llaboratory studies about psychotic spectrum disorders.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.